Trishula Revenue and Competitors

Location

Total Funding

Industry

Estimated Revenue & Valuation

Name	Title	Email/Phone
1 Thomas Jahn	Chief Medical Officer	Reveal Email/Phone
2 Siddhartha Mitr...	Chief Medical Officer	Reveal Email/Phone
3 Anh Tran	Executive Director Clinical Operations	Reveal Email/Phone
4 Sapna Mistry	Senior Director Project Management	Reveal Email/Phone

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 DiaCarta	$4.4M	57	-8%	$53M	N/A
#2 Mission Bio	$21.2M	137	-26%	$110M	N/A
#3 Quadrants Scien...	$0.9M	6	0%	N/A	N/A
#4 Calcilytix Ther...	$2.3M	15	15%	N/A	N/A
#5 Ravata Solution...	$1.6M	10	-17%	N/A	N/A
#6 Range Biotechno...	$0.7M	9	50%	N/A	N/A
#7 Mission Barns	$11.5M	74	-12%	N/A	N/A
#8 Geron Corporati...	$0.4M	275	10%	$236.7M	N/A
#9 Mindstrong	$4M	51	-74%	$160M	N/A
#10 CalciMedica	$2.3M	15	15%	N/A	N/A

keywords:N/A

N/A

Total Funding

Number of Employees

$3.1M

Revenue (est)

18%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Trishula Therapeutics Announces Promising Early Phase 1b Data of TTX-030, an Anti-CD39 Antibody, in Combination with Chemoimmunotherapy as First...

Trishula Therapeutics has reported encouraging initial data from an ongoing Phase I trial of its anti-CD39 antibody TTX-030 with budigalimab...

Trishula is a privately held company dedicated to the development of TTX-030, a first-in-class, anti-CD39 antibody, in collaboration with AbbVie...

Company Name	Revenue	Number of Employees	Employee Growth	Total Funding
#1 Royal Cafe	$3.8M	20	-77%	N/A
#2 Saleae	$3.4M	20	0%	N/A
#3 Vital Restorati...	$4.1M	20	11%	N/A
#4 Achaogen	$1.6M	21	-32%	$178.7M
#5 Amphivena Thera...	$3.3M	21	-19%	N/A